Editorial Comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-01
著者
関連論文
- Thiol crosslinking agent Diamide was effective to induce apoptosis in multidrug resistant TCC cells
- Adoptive Immunotherapy of Patients with Metastatic Renal Cell Cancer Using Lymphokine-Activated Killer Cells, Interleukin-2 and Cyclophosphamide: Long-Term Results
- Serum ICAM-1 in Renal Cell Cancer Patients : Possible Significance for Presence of Metastatic Disease
- A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer
- S9: Introduction(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)
- CORRELATION OF p53 PROTEIN EXPRESSION IN HUMAN UROTHELIAL TRANSITIONAL CELL CANCERS WITH MALIGNANT POTENTIAL AND PATIENT SURVIVAL
- The prevalence of renal cell carcinoma : A nation-wide survey in Japan in 1997
- Early renal cell cancer
- Absence of RET Proto-Oncogene Mutations in a Father and Son with Pheochromocytoma and Pancreatic Islet Cell Tumor
- Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy
- Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate
- Editorial Comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients
- Reduced-intensity stem cell transplantation in two cases of metastatic renal cell carcinoma
- Exploring immune therapy for renal cancer